“…As mentioned initially there is cytogenetic evidence that the erythroblasts in acute mye loid leukaemia are of leukaemic origin [2,4,11,15,16] and studies with thymidine labelling [4,9,13,17,22] have indicated abnormal ki netic properties. It is interesting in this context to note that H uber et al [13] and Queisser et al [17] found low labelling indices of erythro blasts in AML but that in the present investigation high mitotic indices were found. Ernst et al [7] found a similar discrepancy between thymi dine-labelling indices and mitotic indices of erythroblasts in patients with AML and suggested that the low utilization of labelled thymidine might be a biochemical expression of 'leukaemicness' of the erythroid cells.…”